Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NRG2 mRNA | affects expression | 16483693
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NRG2 mRNA | decreases expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of NRG2 mRNA | decreases expression | 16002434
|
D008345 |
Manganese |
Manganese results in increased expression of NRG2 mRNA | increases expression | 17175027
|
C025340 |
manganese chloride |
manganese chloride results in increased expression of NRG2 mRNA | increases expression | 17175027
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NRG2 mRNA | affects binding|increases activity|increases expression | 19710929
|
D020849 |
Raloxifene |
Raloxifene results in increased expression of NRG2 mRNA | increases expression | 15849065
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of NRG2 mRNA | affects expression | 21346803
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
4.52 | 7525203 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.90 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.38 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.82 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.88 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.58 | 15800139 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
11.85 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
11.85 | 16910769 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.39 | 19483382 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.78 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.44 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.44 | 15572757 17595753 15758505 17049068 17893378 16912660 15775269 16837676 17242785 17440819 17952589 17261762 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.68 | 11237771 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.30 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.60 | 15775269 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
4.00 | 15817613 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.68 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.35 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.35 | 19176532 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.92 | 15800139 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
4.61 | 15095906 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
5.23 | 18551238 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.38 | 17474826 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.52 | 18249437 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
4.15 | 17308373 17451421 15920148 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
2.93 | 18551238 21346803 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.70 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
7.70 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
10.34 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
10.34 | 15845917 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.57 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
14.57 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
14.57 | 17473493 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.45 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.56 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
4.06 | 17043766 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.69 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.67 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.76 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.79 | 18467677 19176532 16221962 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
9.79 | 15817613 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.41 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.56 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
5.56 | 17577099 15787275 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
3.83 | 12150543 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.78 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.82 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.46 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.93 | 12371664 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.76 | 16973256 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.89 | 20007298 16377806 15890375 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
5.90 | 16551646 19453300 16568477 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.16 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.93 | 15863610 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
5.27 | 16551646 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.60 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.81 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.22 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.13 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.93 | 16343187 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
5.10 | 18551238 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.05 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.82 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.50 | 18481113 19348381 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
4.46 | 16551646 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
4.56 | 17852074 12819281 14694615 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.53 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.49 | 17823083 15758505 17893378 15579764 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
3.44 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.70 | 16140633 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.44 | 12371664 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.12 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.46 | 16289102 18247401 16644109 12479363 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.46 | 16536755 15731164 16220300 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.93 | 15770314 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.49 | 19058328 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
3.59 | 18551238 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
5.51 | 15817613 |
MESH:D020521 |
Stroke |
|
Raloxifene |
4.01 | 16837676 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.58 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
2.89 | 17572228 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.36 | 1336536 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.58 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.93 | 16343187 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.82 | 17120751 |